Oncology News, Insights, Stories by OncoDaily

Sleep Needs of Childhood Cancer Patients by SIOP GHN Psychosocial Wellbeing WG
2025-03-26 15:00 - 17:00 (America/Sao_Paulo)
Sleep Needs of Childhood Cancer Patients by SIOP GHN Psychosocial Wellbeing WG will be held on March 26, 2025, Virtually.
The Sleep Needs of Childhood Cancer Patients webinar, organized by the SIOP GHN Psychosocial Wellbeing WG, will focus on the increased risk of sleep disturbances in children and adolescents with cancer. This population faces sleep challenges due to illness-related factors, treatment-induced symptoms, psychological and emotional issues, and environmental disruptions. Most existing interventions to address sleep problems have been validated in healthy children, not specifically those with cancer. The session will discuss tailored interventions at both the individual and environmental levels to better address the unique sleep needs of young cancer patients.
Online registration is available until March 26, 2025.

European Lung Cancer Congress 2025
2025-03-26 11:00 - 2025-03-29 14:00 (Europe/Helsinki) | Paris Expo Porte de Versailles, 2 Pl. de la Prte de Versailles, Paris, 92170, France
The European Lung Cancer Congress 2025 will be held in Paris, France, on March 26-29, 2025, with an online option available through the LIVE Plus format.
This congress unites leading specialists in thoracic oncology—medical oncologists, radiation oncologists, thoracic surgeons, and more—to share knowledge and improve lung cancer care. Attendees can look forward to a dynamic program filled with valuable insights and networking opportunities. The event is organized by the European Society for Medical Oncology and the International Association for the Study of Lung Cancer.
Registration is still open for the event.
Find more information featuring ELCC2024 at OncoDaily.com.

Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM)
2025-03-25 00:00 - 2025-03-29 00:00 (Europe/Helsinki)
Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) will be held from March 25, 2025 – May 29, 2026. It’s a hybrid event and the offline venues will change either.
The Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) is a joint collaboration between the European School of Oncology (ESO) and the University of Fribourg, Switzerland. The programme will focus on the improvement on both the clinical and the scientific aspects of improving quality in the management of patients with lung cancer and other thoracic malignancies. Upon successful completion of the programme, participants will obtain an academic certificate assigning 14 ECTS credits, equalling a work load of 420 hours and a diploma supplement by the University of Fribourg.

Informal meeting of health ministers
2025-03-24 08:00 - 2025-03-25 17:00 (Europe/Warsaw) | Warsaw, Poland, Warsaw, Poland
Informal meeting of health ministers will be held from March 24-25, 2025 at Warsaw, Poland.
While official Council meetings are organized by the Council of the EU and chaired by the Council presidency, each presidency also arranges informal gatherings of ministers to discuss specific initiatives or topics relevant to their area of focus. This meeting will provide a platform for health ministers to exchange views and collaborate on key health-related initiatives within the EU.

The ESTRO Particle Therapy Course
2025-03-23 10:00 - 2025-03-27 12:30 (America/Sao_Paulo)
The ESTRO Particle Therapy Course will be held from March 23-27, 2025 at Maastricht, The Netherlands.
This course is designed for radiation oncologists, medical physicists, and professionals in related fields, including trainees, who are interested in particle therapy. It is aimed at individuals with a basic understanding of radiation oncology and radiation physics. Participants who are currently involved in clinical particle therapy projects, practice particle therapy, or wish to update their knowledge in this area will benefit from the course. The content covers fundamental and advanced topics in particle therapy, equipping participants with the necessary knowledge to enhance their expertise and practice in this specialized field of radiation treatment.

A key part of the program includes guidance on how to develop a particle therapy facility, from project planning to starting clinical operations, as well as expanding existing radiotherapy departments to include particle therapy. A guided tour of a local particle therapy facility will provide a real-world perspective on the implementation of the techniques discussed. Participants are required to have a basic understanding of radiobiology, radiation physics, and radiotherapy planning before attending the course.

Early date for Registration is January 10.

The EAU 2025 Congress
2025-03-21 08:00 - 2025-03-24 16:30 (Europe/Madrid) | IFEMA Madrid, Avda. del Partenón, 5, Madrid, Spain
The EAU 2025 Congress will be held from March 21-24, 2025 at Madrid, Spain.
The 40th Annual EAU Congress is Europe’s premier event in urology, gathering specialists and medical professionals from around the world to evaluate and discuss the latest clinical practices and research advancements. The congress offers a variety of educational formats, including state-of-the-art lectures, HD video surgery sessions, hands-on training, and practical courses aimed at enhancing skills. As the largest and most influential gathering in urology, the event continues its four-decade tradition of presenting cutting-edge science and fostering collaboration among global urological experts.
Registration is open for the event.

Refresher course for diagnosis and management of early-stage lung cancer by ESO
2025-03-20 18:00 - 2025-03-22 12:00 (America/Sao_Paulo) | Belgrade, Belgrade, Serbia
Refresher course for diagnosis and management of early-stage lung cancer by ESO will be held at Belgrade, Serbia from March 20-22, 2025.
This course is designed to provide a comprehensive understanding of the latest diagnostic and therapeutic approaches in the diagnosis and management of early-stage lung cancer. The primary goal is to enhance multidisciplinary collaboration between respiratory physicians, thoracic surgeons, and oncologists to ensure accurate diagnosis, staging, and the development of individualized treatment plans. Emphasizing the latest advancements in imaging techniques, biopsy procedures, molecular testing, oncology, and surgical management, the course will equip participants with the essential skills to accurately assess and treat early-stage lung cancer. This will ensure that patients receive timely, targeted, and effective interventions.
The course aims to deepen participants’ knowledge of both surgical and non-surgical treatment options. This includes minimally invasive techniques, stereotactic body radiotherapy (SBRT), and the role of adjuvant therapies. By incorporating case-based learning and evidence-based guidelines, the course will help foster a patient-centered approach to care. This approach emphasizes the importance of shared decision-making and long-term follow-up for improving patient outcomes. The ultimate goal is to empower physicians to optimize treatment outcomes, reduce recurrence rates, and enhance patient survival and quality of life.

Falcon Workshop on Prostate SBRT by ESTRO
2025-03-20 18:00 - 20:00 (America/Halifax)
Falcon Workshop on Prostate SBRT by ESTRO will be held at March 20 and 27, 2025, Virtually.
This workshop is aimed at those involved in prostate radiotherapy contouring, including trainee oncologists, established oncologists, and contouring radiographers. It focuses on improving contouring accuracy, a key source of error in radiotherapy. The course includes practical contouring exercises, feedback from experts, and guidance on common pitfalls, with examples from the PACE trial’s quality assurance process.
Participants will complete pre-workshop homework and attend two online sessions. In the first, faculty will present guidelines and review initial contours, while in the second, revised contours will be compared to reference contours with feedback provided. CME accreditation is being applied for through EACCME, with credits recognized by the American Medical Association.

Paediatric Integrative Oncology in Chile: A comprehensive approach to cancer care
2025-03-20 16:00 - 17:00 (America/Sao_Paulo)
Paediatric Integrative Oncology in Chile: A comprehensive approach to cancer care will be held on March 20, 2025, Virtually.
The Pediatric Integrative Oncology in Chile: A Comprehensive Approach to Cancer Care webinar offers insights into how integrative care is incorporated into the treatment of pediatric cancer patients in southern Chile. The session will highlight the use of complementary therapies to help reduce the adverse effects of chemotherapy, especially in a setting with limited resources. Participants will learn about the strategies employed to provide comprehensive care and improve patient outcomes through the integration of these therapies.
Online registration is available until March 3rd, 2025.

Update Meeting by the Supportive Care Network
2025-03-20 14:00 - 17:00 (America/Sao_Paulo)
Update Meeting by the Supportive Care Network will be held on March 20, 2025, Virtually.
Update Meeting by the Supportive Care Network at the SIOP conference covers key updates in pediatric oncology care. Topics include SIOP news, updates on regional Supportive Care Networks, and project updates on areas like pediatric oncology rehabilitation and transfusion therapy. The meeting provides a platform for professionals to collaborate and share the latest advancements aimed at improving supportive care and outcomes for children with cancer.
Online registration is available until March 20th, 2025.

ESMO Sarcoma and Rare Cancers Congress 2025
2025-03-20 08:00 - 2025-03-22 13:00 (Europe/Helsinki) | Palazzo dei Congressi, piazza dell' Indipendenza 4, Lugano, 6900, Switzerland
The ESMO Sarcoma and Rare Cancers Congress 2025 will be held at the Palazzo dei Congressi in Lugano, Switzerland, on March 20-22. This event is organized by the European Society for Medical Oncology and will focus on the latest developments in the diagnosis, treatment, and biology of rare solid tumors, providing a comprehensive look at this rapidly evolving field.
Whether you’re an oncologist, researcher, healthcare professional, industry leader, or patient advocate, this congress offers valuable insights and discussions aimed at improving care and outcomes for patients with sarcomas and rare cancers. Don’t miss this opportunity to connect and collaborate with experts in the field!
Registration is open for the event.
Find more articles featuring ESMO at OncoDaily.com.

The Masters in Therapeutic Oncology Summit - Genitourinary Edition
2025-03-20 00:00 - 2025-03-23 00:00 (America/Halifax) | The Ballantyne Hotel, Charlotte, Ballantyne Commons Parkway Charlotte, Charlotte, 28277, United States
The Masters in Therapeutic Oncology Summit – Genitourinary (GU) Edition (MaTOS-GU) will be held from March 20-23, 2025 at The Ballantyne, Charlotte.
The Masters in Therapeutic Oncology Summit – Genitourinary (GU) Edition (MaTOS-GU) is a groundbreaking event designed to address the evolving challenges in the treatment of GU tumors. This summit brings together key opinion leaders (KOLs) in GU oncology for two intensive days of knowledge exchange, focused discussions, and real-world case analysis. Participants review the latest research, therapeutic approaches, and clinical applications, providing an invaluable platform for sharing insights and strategies. The collaborative environment encourages deep dives into the complexities of GU oncology, bridging the gap between research and practice to enhance patient outcomes.

The 2025 Radiosurgery Society (RSS) Scientific Meeting
2025-03-20 00:00 - 2025-03-22 00:00 (America/Halifax) | Westin La Paloma, 3800 East Sunrise Drive Tucson, AZ, Tucson, AZ, 85718, United States
The 2025 Radiosurgery Society (RSS) Scientific Meeting will take place in Tucson, Arizona, from March 20-22, 2025, offering a unique opportunity for healthcare professionals from various disciplines to come together and explore the latest advancements in stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), and precision therapies. This collaborative, multi-disciplinary conference will feature world-class experts in the field who are passionate about enhancing patient care through innovative treatment strategies.
The meeting will showcase cutting-edge discoveries, clinical research, and technological advancements in SRS and SBRT. These techniques, known for their precision and effectiveness, are transforming the way healthcare providers treat a variety of conditions, including cancer and other complex diseases. Attendees will have the chance to engage in discussions on the most recent developments in these therapies, furthering their knowledge and skills to improve patient outcomes.
The Link for Registration.

CSO Journal Club - Discussing Prognosis with Patients with Advanced Cancer
2025-03-19 19:00 - 20:00 (Australia/Sydney)
CSO Journal Club – Discussing Prognosis with Patients with Advanced Cancer will be held on March 19th, Virtually.
It will feature Dr. Anuradha Vasista and Dr. Deme Karikios. This event will focus on the important topic of effectively communicating prognosis with patients diagnosed with advanced cancer. The session will explore the nuances of these conversations, offering insights on how to approach sensitive discussions, address patient concerns, and provide support throughout the decision-making process. Attendees will gain valuable perspectives on how to navigate complex prognosis conversations in a compassionate and clear manner to improve patient understanding and care outcomes.
Registration is open.

NCI Symposium on Translational Technologies for Global Health
2025-03-19 00:00 - 2025-03-20 00:00 (America/Halifax) | NIH Main Campus Natcher Auditorium, 9000 Rockville Pike Bethesda, MD, Bethesda, 9000, United States
NCI Symposium on Translational Technologies for Global Health will be held from March 19-20, 2025 at NIH Main Campus Natcher Auditorium.
This two-day conference will bring together researchers, technology developers, clinicians, and industry partners from NCI-funded grants and contracts to advance and translate new and emerging technologies for global oncology. Participants will include regulatory administrators, NGO leaders, and a diverse range of stakeholders, all focused on accelerating global health technology innovation, validation, and commercialization.
The agenda will feature plenary panels of ACTs investigators, scientists from related programs, industry stakeholders, and notable figures from USG and global oncology organizations. Additionally, a technology showcase will provide an opportunity for symposium participants to engage directly with the innovative technologies being developed within these programs.
Registration is open for the event.

The POC NOW 2025
2025-03-18 10:00 - 17:30 (America/Halifax) | Pier Sixty, 60 Chelsea Piers, New York, United States
The POC NOW 2025 will be held at March 18, 2025 at New York, US.
The POC NOW 2025 Summit gathers healthcare marketers, pharmaceutical decision-makers, agency leaders, and Point of Care (POC) experts to explore the continued growth and impact of POC in a rapidly changing healthcare landscape. As healthcare evolves with shifting patient behaviors, emerging technologies, and increasing digitization, POC remains a key, adaptable channel that connects patients, caregivers, and providers at crucial moments.
This year’s theme, “A Foundation for Healthcare Engagement,” emphasizes POC’s ongoing value in supporting care delivery and fostering stronger relationships. The summit aims to provide actionable insights and strategies to help the community shape the future of healthcare communication with confidence.
Registration is open for the event.

The YO4YO Virtual Session Series by ESMO
2025-03-17 18:00 - 19:00 (America/Halifax)
The YO4YO Virtual Session Series by ESMO will be held on March 17th, 2025, Virtually.
The “YO Virtual Mentorship and Career Development Series” is designed to provide young oncologists with a platform for professional growth through interactive web events. It includes mentorship sessions where experts offer guidance on navigating different career paths, as well as clinical case discussions, allowing participants to engage with leaders and researchers to tackle challenging cases across various tumor types.
Additionally, the series features “HowTo” sessions, focusing on practical aspects of professional development, such as publications, grant applications, and other key skills. These sessions provide young oncologists with valuable insights and opportunities to network with colleagues and leaders in the field, supporting their growth in oncology.
Join the meeting with this link.

Breaking barriers: ensuring equal cancer care access for diverse communities by SPCC
2025-03-17 18:00 - 19:00 (America/Halifax)
Breaking barriers: ensuring equal cancer care access for diverse communities by SPCC will be held at March 17, 2025, Virtually.
This event focuses on addressing health disparities in cancer care and the importance of achieving health equity for all patients. It highlights the significant impact of social drivers of health such as socioeconomic status, race, and access to resources on patient outcomes, caregivers, and clinical teams. The session will explore how these barriers can be overcome to ensure equal access to treatment and care for everyone, regardless of their background.
The event features presentations from experts, including Nicolò Matteo Luca Battisti, Joseph Gligorov, and Stewart O’Callaghan. The discussions aim to shed light on successful initiatives, explore how far we’ve come in fostering equality in cancer care, and identify the next steps needed to make further progress.

EHA Research Conference 2025
2025-03-17 00:00 - 2025-03-20 12:00 (Europe/Helsinki) | Hotel Sol Marbella Estepona Atalaya Park, Av. de las Golondrinas, 2, 29688 Estepona, Malaga, 29688, Spain
EHA Research Conference 2025 will be held at Malaga, Spain from March 17-20.
EHA is excited to announce the third edition of the EHA Research Conference, focusing on the theme ‘Transcriptional Control and Chromatin Alterations in Normal and Abnormal Hematopoiesis.’
Spanning 3.5 days, the conference will provide ample time for in-depth discussions, networking, and social activities, fostering collaboration and exchange among participants. The goal of the 2025 meeting is to explore, synthesize, and discuss key topics related to transcriptional regulation and chromatin changes in both healthy and diseased hematopoiesis.
Registration is open for the event.

UC San Diego Kidney Cancer Patient Summit 2025
2025-03-15 08:00 - 14:30 (America/Denver) | The Alexandria at Torrey Pines, 10996 Torreyana Road, San Diego, CA, 10996, United States
Join for the first-ever Kidney Cancer Patient Summit on March 15, 2025, at the Alexandria at Torrey Pines organized by the UCSD Moores Cancer Center.
This event will bring together patients, caregivers, and experts for a day of learning, networking, and support. Enjoy interactive sessions with specialists, connect with others in the kidney cancer community, and stay informed about the latest research and treatment advances. Complimentary registration for patients and caregivers.
Don’t miss this opportunity to gain valuable insights and share stories of hope.
Register now!

Improving care of Early Breast Cancer (EBC) patients in Europe Investigators Meeting by SPCC
2025-03-12 09:00 (Europe/Helsinki) | Vienna, Austria, Vienna, 1300, Austria
Improving care of Early Breast Cancer (EBC) patients in Europe Investigators Meeting by SPCC will be held at Vienna, Austria at 12 March 2025.

This activity, supported by Eli Lilly and Company in collaboration with SPCC, was designed to bring together healthcare professionals and innovative organizations to identify gaps in the treatment of Early Breast Cancer and develop strategies to improve care and address those gaps. The initiative aimed to facilitate the involvement of patients, caregivers, and families in collaborative decision-making processes, while also employing evidence-based educational strategies aligned with the desired outcomes of the intervention.

Upper GI: Technical and Clinical challenges for Radiation Oncologists by ESTRO
2025-03-08 13:00 - 2025-03-11 12:30 (Europe/Lisbon) | Jupiter Hotel, Avenida da Republica, 46, Lisbon, 1050-195, Portugal
Upper GI: Technical and Clinical challenges for Radiation Oncologists by ESTRO will be held from 8-10 March, 2025 at Lisbon, Portugal.
The Upper GI: Technical and Clinical Challenges for Radiation Oncologists course focuses on addressing the evolving role of radiotherapy in the treatment of upper gastrointestinal (GI) tumors, which are known for their unfavorable prognosis. Despite these challenges, there is significant potential for improvement through technological innovations and a multidisciplinary approach.
The course provides an interactive educational environment where participants can engage in peer reviews at each stage of radiation therapy practice, including indication, prescription, delineation, planning, IGRT, and outcome evaluation. The course incorporates the latest state-of-the-art technologies and knowledge while considering the perspectives of clinicians, physicists, and radiation therapy technologists (RTTs).
Specialists from various disciplines will guide participants in understanding the clinical, anatomic, and pathological aspects of upper GI tumors, as well as the therapeutic advancements required for optimal radiation oncology practice. By the end of the course, participants will be equipped to appropriately indicate radiation therapy, prescribe treatments, tailor delineation based on tumor location and stage, optimize dose distribution, utilize IGRT technologies effectively, and monitor tumor response and control.

4th How to Diagnose and Treat: CML/MPN by ESH
2025-03-07 09:00 - 2025-03-09 14:00 (America/Sao_Paulo) | Austria Trend Hotel Savoyen, Rennweg 16, Vienna, 1030, Austria
4th How to Diagnose and Treat: CML/MPN will be held at Vienna, Austria from March 7-9, 2025.
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
Building on the success of the previous three meetings, this year’s programme will immerse attendees in the most current information and strategies for managing both common and rarer clinical scenarios across the spectrum of Chronic Myeloid Leukemia (CML), Myeloproliferative Neoplasms (MPN), and related conditions. The focus will be on practical, evidence-based management approaches tailored to real-world challenges.
Registration is open for the event.

Strategic Leading and Management in the Cancer Care Continuum by SPCC
2025-03-07 07:00 - 2025-03-08 17:00 (Europe/Helsinki) | Milan, Italy
Basic skills in “Strategic Leading and Management in the Cancer Care Continuum” by SPCC will be held from March 7-8, 2025 at Milan, Italy.
The leadership and management skills in the Cancer Care Continuum are becoming increasingly important for medical and clinical staff, as they must be prepared to address the challenges, dynamics, and complexity of modern healthcare. This includes fast-paced technological advancements, growing patient needs, and limited resources, particularly in oncology.
In response, SPCC plans to launch a basic course in “Strategic Leading and Management in the Cancer Care Continuum.” This educational program is designed to enhance participants’ understanding of management skills and develop the capabilities needed to become effective leaders in the field.
Registration is open for the event.

Radiotherapy for Rhabdomyosarcoma by SIOP
2025-03-06 15:00 - 17:00 (America/Halifax) | https://us06web.zoom.us/webinar/register/WN_t2pmKPE3QxiK0RBRQANPvA#/registration
The upcoming lecture, Radiotherapy for Rhabdomyosarcoma, will take place on March 6, 2025, at 15:00 CET, Virtually.
The event will be part of the Educational Lectures on Paediatric Radiation Oncology Series, focusing on one of the most common soft tissue cancers in children. Hosted by the West German Proton Therapy Center Essen (WPE), along with the SIOP GHN PROS Working Group and PROS, this event aims to provide specialized knowledge and insights into the role of radiotherapy in treating rhabdomyosarcoma, a rare and aggressive tumor.
The session will feature expert speakers in the field of pediatric radiation oncology who will discuss the latest advancements, techniques, and strategies in treating rhabdomyosarcoma. Attendees can expect to learn about both conventional and cutting-edge radiotherapy methods, as well as the challenges and considerations when treating this complex cancer in young patients. therapy to enhance their.
The link to the meeting.

The EUHPP Live Webinar Series 3
2025-03-06 10:00 - 11:30 (Europe/Brussels)
The EUHPP Live Webinar Series 3 will be held on March 6th, 2025, Virtually.
The EUHPP Live Webinar Series 3 will focus on the essential steps that Member States need to take to implement the European Health Data Space (EHDS). This session will delve into the roles of digital health authorities and health data access bodies, providing actionable guidance on building the necessary infrastructure, establishing governance frameworks, and ensuring operational readiness.
Participants will gain a clear understanding of their responsibilities in the implementation process and the resources available to assist them. The presentation, titled “Implementation and Governance – Who Does What?”, aims to equip stakeholders with practical knowledge for driving the successful roll-out of the EHDS.
Registration is open for the event.

SACT 2025
2025-03-06 00:00 - 2025-03-09 00:00 (America/Halifax) | Tata Memorial Centre, Dr. E Borges Road, Parel, Mumbai, Maharashtra, Mumbai, 400012, India
SACT 2025 will be held at Mumbai, India from March 6-9, 2025.
The SACT 2025 Conference will feature various key programs designed to advance knowledge and practices in cancer care and treatment. The Translational Pathway Program will focus on the latest research and breakthroughs in translational oncology, bridging basic science with clinical application. The Clinical Pathway Program will delve into the practical aspects of cancer treatment, offering insights on optimizing clinical practices and patient care.
The Roundtable Sessions will provide an interactive platform for participants to engage in in-depth discussions on critical topics in oncology, fostering collaboration and knowledge exchange. The Abstracts Session will showcase cutting-edge research, allowing researchers to present their findings and receive feedback from their peers. Global Showcases will highlight innovative approaches to cancer treatment and care from across the globe, providing diverse perspectives and solutions.

People, places, and platforms that support a cancer patient’s journey by SPCC
2025-03-05 18:00 - 19:00 (America/Halifax)
People, places, and platforms that support a cancer patient’s journey by SPCC will be held at March 5, 2025, Virtually.
This conference focuses on the various people, places, and platforms that support a cancer patient’s journey. It highlights the importance of a comprehensive support network that goes beyond medical treatment. Compassionate healthcare professionals, supportive family members, specialized medical centers, and digital innovations all play a vital role in providing comfort, guidance, and resources.
These interconnected elements help empower patients to face their cancer journey with resilience and strength. The session will feature speakers Aleksandra Filipovic, Steve Bierman, and Alejandro Piris, who will share their insights on how these diverse forms of support contribute to improving patient outcomes.

ESMO Targeted Anticancer Therapies Congress 2025
2025-03-03 11:00 - 2025-03-05 16:00 (Europe/Paris) | Paris Marriott Rive Gauche Hotel, 17, Boulevard St. Jacques, Paris, 75014, France
The ESMO Targeted Anticancer Therapies Congress 2025, will be held from March 3-5 in Paris, France.
It is organized by the European Society for Medical Oncology. This essential multi-stakeholder forum brings together researchers, industry partners, investors, and regulatory bodies, creating a unique opportunity for professionals involved in the development of new anticancer drugs.
This is a fantastic chance to connect in Paris, share the latest data, foster collaboration, and tackle the challenges we face in accelerating the path from bench to bedside for the benefit of our patients. Don’t miss out on being part of this important conversation!
Register here.
Find more information featuring ESMO at OncoDaily.com.

The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO
2025-03-01 00:00 - 2025-03-05 00:00 (America/Halifax)
The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO will be going on for two years from March 2025 to November 2026.
The Nordic Radiotherapy Diploma Programme (NORTHDIP) is a two-year advanced education initiative designed for clinical oncologists across the Nordic countries: Denmark, Iceland, Finland, Norway, and Sweden. The programme addresses the need for supplementary radiotherapy training for oncologists who specialize in radiotherapy after their clinical oncology education.
The goal of NORTHDIP is to enhance radiotherapy skills and foster collaboration among Nordic clinical oncologists, ultimately advancing expertise in the region and promoting collaborative research and development in radiotherapy.
The programme’s content is aligned with ESTRO’s core curriculum for radiation oncologists and covers a variety of advanced topics:

Sweden 2024: Advanced radiophysics, dose planning, organs-at-risk constraints, and advanced technologies.
Norway 2025: Radiobiology, benign diseases, and palliative care.
Finland 2025: Reirradiation, stereotactic radiotherapy, and BNCT (Boron Neutron Capture Therapy).
Denmark 2026: Adaptive radiotherapy and imaging (CBCT, dual-energy CT, PET-CT, MRI), including the integration of proton and MR-Linac therapy.
Iceland 2026: Nordic research protocols, including the design of clinical trials for collaborative Nordic implementation and shared patient recruitment.
